ArticleTheranostics2024

Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.

Yuyang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.